The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death
Keyword(s):
1999 ◽
Vol 3
(1)
◽
pp. 74-81
◽
2018 ◽
Vol 17
(2)
◽
pp. 575-587
◽
Keyword(s):
2018 ◽
Keyword(s):
2005 ◽
Vol 59
(5)
◽
pp. 240-244
◽
Keyword(s):